Secor Capital Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Secor Capital Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,954	Closed	-$1.54M	–	358
2019 Q1	$1.54M	Sell	21,954 -5,097	-19%	-$378K	0.32%	93
2018 Q4	$1.74M	Buy	27,051 +4,694	+21%	+$329K	0.23%	133
2018 Q3	$1.57M	Sell	22,357 -12,845	-36%	-$751K	0.17%	181
2018 Q2	$1.77M	Buy	+35,202	New	+$1.4M	0.15%	207
2017 Q3	–	Sell	-46,551	Closed	-$1.51M	–	585
2017 Q2	$1.51M	Sell	46,551 -1,703	-4%	-$53.9K	0.14%	218
2017 Q1	$1.52M	Sell	48,254 -8,349	-15%	-$247K	0.17%	188
2016 Q4	$1.66M	Sell	56,603 -9,933	-15%	-$303K	0.2%	148
2016 Q3	$1.92M	Buy	66,536 +8,643	+15%	+$241K	0.21%	152
2016 Q2	$1.5M	Buy	57,893 +11,790	+26%	+$313K	0.19%	172
2016 Q1	$1.14M	Buy	46,103 +20,665	+81%	+$567K	0.16%	135
2015 Q4	$895K	Buy	25,438 +14,709	+137%	+$394K	0.25%	131
2015 Q3	$227K	Sell	10,729 -14,920	-58%	-$384K	0.07%	420
2015 Q2	$713K	Buy	25,649 +8,138	+46%	+$230K	0.26%	136
2015 Q1	$535K	Buy	17,511 +4,111	+31%	+$131K	0.21%	170
2014 Q4	$428K	Buy	+13,400	New	+$436K	0.18%	214
2014 Q3	–	Sell	-17,542	Closed	-$481K	–	406
2014 Q2	$481K	Buy	+17,542	New	+$467K	0.25%	139
2014 Q1	–	Sell	-16,984	Closed	-$497K	–	423
2013 Q4	$497K	Buy	+16,984	New	+$539K	0.2%	203

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Secor Capital Advisors's GHDX Position: Q2 2019 in Review

Secor Capital Advisors sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 21,954 shares — an estimated $1.54M sold.

Secor Capital Advisors first reported a position in GHDX in Q4 2013 and held it in 17 quarters. The position peaked at $1.92M in Q3 2016. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

Secor Capital Advisors reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
Secor Capital Advisors sold 21,954 Genomic Health, Inc. shares in Q2 2019, an estimated $1.54M.
Secor Capital Advisors first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 17 quarters.
Secor Capital Advisors's Genomic Health, Inc. position peaked at $1.92M in Q3 2016.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Secor Capital Advisors's 13F filing for Q2 2019.